| Efluelda 0.7 ml, suspension injectable en seringue préremplie - 10 |
| 67704021 | | Sanofi-Aventis (Suisse) SA | | Efluelda 0.7 ml, suspension injectable en seringue préremplie | | 21.07.2021 | | | | | 16.08.2024 | | Influenza, gereinigtes Antigen (J07BB02) | | | | WHO-DDD | | 20.07.2026 | | 08.08. | | 10 | | 08.08. | | | | B | | | | Nein | | | | FI | | | | PA | | | | k.A. | | PA | | FB | | | | 7680677040214 | | Impfstoffe | | | | |
|
| Zusammensetzung |
| haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/4897/2022 (H1N1)-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 60 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Thailand/8/2022 (H3N2)-like: reassortant virus SAN-022 derived from A/California/122/2022) 60 µg, haemagglutininum influenzae B (Virus souche B/Austria/1359417/2021-like: derived from B/Michigan/01/2021 (Victoria lineage)(wild type)) 60 µg, haemagglutininum influenzae B (Virus souche B/Phuket/3073/2013 (Yamagata lineage) (wild type)) 60 µg, natrii chloridum, dinatrii phosphas, natrii dihydrogenophosphas anhydricus, octoxinolum-9, aqua ad iniectabile q.s. ad suspensionem pro 0.7 ml corresp. natrium 2.72 mg. |
| Packungsbestandteile |
| suspension injectable en seringue préremplie | | | | | | | | Wirkstoffe | Stärke |
|---|
| Haemagglutininum Influenzae a (H1N1) (Virus Souche A/victoria/4897/2022 (H1N1)-Like: Reassortant Virus Ivr-238 Derived from A/victoria/4897/2022) | 60µg / 0.7ml | | Haemagglutininum Influenzae a (H3N2) (Virus Souche A/thailand/8/2022 (H3N2)-Like: Reassortant Virus San-022 Derived from A/california/122/2022) | 60µg / 0.7ml | | Haemagglutininum Influenzae b (Virus Souche B/austria/1359417/2021-Like: Derived from B/michigan/01/2021 (Victoria Lineage)(wild Type)) | 60µg / 0.7ml |
| | BAG: Wirkstoffe | Stärke |
|---|
| Influenza-hämagglutinin | 240 mcg |
| | | | Hilfsstoffe | Stärke |
|---|
| Dinatrium Phosphat | | | Haemagglutininum Influenzae b (Virus Souche B/phuket/3073/2013 (Yamagata Lineage) (Wild Type)) | 60µg / 0.7ml | | Natrium Chlorid | | | Natrium Dihydrogenophosphat Anhydrid | | | Octoxinolum-9 | |
| |
|
| Quelle |
| Datum des Datenimports : 05.09.2024
Swissmedic-Registration :
Sequenz :
Präparatname :
Zulassungsinhaber: :
Produktgruppe :
Index Therapeuticus (BSV) :
Heilmittelcode :
Registrierungsdatum :
Gültig bis :
Packungsnummer :
Packungsgrösse :
Handelsform/Einheit :
Abgabekategorie :
Wirkstoffe :
Zusammensetzung :
|
|
|
